Claritev Pre-Tax Profit Margin 2019-2025 | CTEV
Claritev pre-tax profit margin from 2019 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Claritev Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $0.93B | $-1.30B | -140.28% |
| 2024-12-31 | $0.93B | $-1.77B | -190.43% |
| 2024-09-30 | $0.94B | $-1.62B | -171.66% |
| 2024-06-30 | $0.96B | $-1.23B | -128.69% |
| 2024-03-31 | $0.96B | $-0.67B | -69.90% |
| 2023-12-31 | $0.96B | $-0.11B | -11.12% |
| 2023-09-30 | $0.96B | $-0.72B | -75.39% |
| 2023-06-30 | $0.97B | $-0.68B | -70.70% |
| 2023-03-31 | $1.02B | $-0.62B | -60.61% |
| 2022-12-31 | $1.08B | $-0.56B | -51.99% |
| 2022-09-30 | $1.14B | $0.12B | 10.65% |
| 2022-06-30 | $1.17B | $0.21B | 17.89% |
| 2022-03-31 | $1.16B | $0.13B | 11.55% |
| 2021-12-31 | $1.12B | $0.14B | 12.09% |
| 2021-09-30 | $1.07B | $-0.09B | -8.10% |
| 2021-06-30 | $1.01B | $-0.47B | -46.93% |
| 2021-03-31 | $0.94B | $-0.48B | -51.43% |
| 2020-12-31 | $0.94B | $-0.55B | -58.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.472B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.174B | 54.11 |
| Hims & Hers Health (HIMS) | United States | $13.701B | 142.35 |
| Tempus AI (TEM) | United States | $10.751B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.508B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.426B | 69.15 |
| Privia Health (PRVA) | United States | $2.989B | 204.33 |
| Enovis (ENOV) | United States | $1.969B | 10.98 |
| Clover Health Investments (CLOV) | United States | $1.878B | 0.00 |
| Schrodinger (SDGR) | United States | $1.573B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Omnicell (OMCL) | United States | $1.348B | 23.78 |
| Azenta (AZTA) | United States | $1.294B | 60.15 |
| 10x Genomics (TXG) | United States | $1.118B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 150.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 830.67 |
| Health Catalyst (HCAT) | United States | $0.274B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.192B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.135B | 0.00 |
| American Well (AMWL) | United States | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.090B | 3.42 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |